Dihexa:
Synaptogenesis at the HGF/MET Signaling Level

Full name

N-hexanoic-Tyr-Ile-(6) aminohexanoic amide (PNB-0408)

Derived from

Angiotensin IV analogues, Washington State University (Harding et al.)

Primary mechanism

HGF/MET receptor potentiation → synaptogenesis, dendritic spine formation, LTP facilitation

Preclinical potency

Estimated 10⁷ × more potent than BDNF for synaptogenesis in preclinical models

Delivery

Oral capsule, 5mg and 25mg formulations

Human data

Limited: primarily preclinical research base; novel compound with developing human evidence

HGF/MET Receptor Potentiation

Hepatocyte growth factor (HGF) and its receptor tyrosine kinase MET are expressed in the hippocampus and prefrontal cortex, where HGF/MET signaling drives synaptogenesis, axonal branching, neuronal survival, and synaptic plasticity. Dihexa acts not as a direct MET agonist but as an HGF potentiator. It enhances the binding efficiency of endogenous HGF to MET, amplifying downstream signaling without requiring exogenous HGF. The downstream MET signaling cascade activates Rac1 and Cdc42 (small GTPases that regulate actin cytoskeleton dynamics), driving the actin remodeling that underlies dendritic spine formation and synaptic structural change.

Synaptogenesis and Dendritic Spine Formation

Dendritic spines are the postsynaptic protrusions where synaptic connections form; each spine represents a potential or active synaptic contact point. Synaptogenesis, the formation of new dendritic spines and synaptic connections, is the cellular correlate of learning, memory consolidation, and cognitive reserve. HGF/MET signaling is one of the primary molecular drivers of hippocampal synaptogenesis. Dihexa's potentiation of this pathway promotes the formation of new dendritic spines in hippocampal and prefrontal neurons, directly increasing synaptic connectivity. In aged animals with impaired synaptogenesis, Dihexa restored dendritic spine density toward youthful levels.

Long-Term Potentiation (LTP) Facilitation

Long-term potentiation is the electrophysiological mechanism of synaptic strengthening. Repeated co-activation of pre- and postsynaptic neurons strengthens their connection, a process considered the cellular basis of memory formation. HGF/MET signaling facilitates LTP in hippocampal circuits. By potentiating this signaling, Dihexa lowers the threshold for LTP induction and enhances the magnitude of synaptic strengthening, supporting more efficient memory encoding and consolidation.

Oral Bioavailability and CNS Penetration

One of the challenges in CNS peptide therapy is blood-brain barrier (BBB) penetration. Most peptides are too large or too hydrophilic to cross efficiently. Dihexa was specifically engineered to address this: its structural modifications (N-terminal hexanoic acid, C-terminal aminohexanoic amide) confer lipophilicity sufficient for passive diffusion across the BBB after oral absorption. This makes it unusual among cognitive peptides. It is effective orally, without injection, with meaningful CNS access.

Distinction from Conventional Nootropics

Most cognitive enhancement compounds (racetams, cholinergics, stimulants) work by modulating neurotransmitter levels or receptor sensitivity. Their effects are present during active pharmacological influence and diminish as the compound clears. Dihexa's mechanism is structural: it promotes the physical formation of new dendritic spines and synaptic connections. Structural changes to synaptic architecture are longer-lasting than neurotransmitter modulation. This distinction matters for both the nature of the cognitive benefit and for protocol design. Synaptogenesis takes time; cognitive benefit may continue to develop and persist after dosing windows close.

Patients Targeting Structural Cognitive Enhancement

Patients who have explored conventional nootropics (racetams, choline, stimulants) and want a compound that operates at the structural level of synaptic architecture rather than neurotransmitter modulation. Dihexa's mechanism is categorically different from these approaches.

Patients with Age-Related Cognitive Decline

Patients experiencing early signs of cognitive aging (slower learning, reduced memory consolidation, executive function decline) who want to address the synaptogenesis reduction that underlies these changes. Dihexa's preclinical reversal of age-related cognitive deficits makes it directly relevant.

Longevity-Oriented Patients Building Cognitive Reserve

Cognitive reserve, the density and resilience of synaptic connectivity, is one of the strongest protectors against age-related cognitive decline. Patients in their 40s and 50s who want to build cognitive reserve before decline begins are a relevant use case.

High-Performance Professionals and Knowledge Workers

Patients for whom cognitive performance is a professional priority (executives, clinicians, academics, entrepreneurs) and who want the most structurally sophisticated cognitive enhancement approach available. Dihexa's orientation toward synaptic capacity aligns with the need for sustained, high-quality cognitive output.

Patients Stacking with Semax, Selank, or Other Cognitive Peptides

Semax promotes BDNF and NGFR signaling; Dihexa potentiates HGF/MET. These are mechanistically distinct neuroplasticity pathways that can be combined. Your provider will advise on appropriate combinations.

Available Formulations

Dihexa is available in two oral capsule strengths: 5mg (30-count, $196.00) and 25mg (30-count, $499.00). The 5mg formulation is appropriate for conservative initial protocols and lower-dose maintenance use. The 25mg formulation is for patients prescribed higher doses or those transitioning from established lower-dose protocols.

Dosing Approach

Dihexa is typically dosed conservatively given its potency. Dosing frequency is often 2 to 3 times per week rather than daily, particularly on initial protocols. Because its mechanism is structural and synaptogenesis accumulates over time, daily administration is not necessarily required. Your provider will establish the appropriate dose and frequency.

Onset Timeline

Because Dihexa's mechanism involves structural synaptic remodeling rather than immediate neurotransmitter modulation, meaningful cognitive benefits typically develop over 2 to 6 weeks rather than being immediately apparent. Patients should evaluate at an appropriate timeline.

Cycle Structure

Dihexa is commonly used in defined cycles of 4 to 8 weeks followed by off periods, rather than continuous use. The structural nature of its mechanism means benefits may persist through off cycles as formed synaptic connections are maintained. Your provider will establish cycle length based on your protocol context.

Stacking Considerations

Dihexa pairs naturally with Semax (BDNF/NGF pathway, complementary neuroplasticity signaling), with NAD+ (neuronal energy substrate supporting synaptogenesis), and with Methylene Blue (mitochondrial electron transport support in high-demand neural tissue). It can also complement BPC-157 for systemic regenerative and neuroprotective effects. Your provider will advise on appropriate combinations.

Choose Your Dose

Start with the 5mg formulation unless you have prior experience with Dihexa or your provider has indicated otherwise. Given Dihexa's potency, conservative initial dosing is the standard approach. The 25mg capsule is appropriate for established protocols at higher prescribed doses.

Complete Your Async Consult

Answer a brief health intake at your own pace. No video call, no waiting room. Describe your cognitive health goals, current medications (particularly psychiatric, neurological, or cardiovascular), and health history. A licensed provider reviews your submission and issues your prescription when clinically appropriate.

Receive, Begin, and Evaluate at the Right Horizon

Your prescription is filled by Optimal Balance Pharmacy and ships via FedEx Standard Overnight. Set a realistic evaluation horizon. Dihexa's structural synaptogenesis mechanism means benefits develop over weeks, not days. Assess at 4 to 6 weeks for a meaningful initial evaluation.

What is Dihexa and how is it different from other nootropics?

What does '7 orders of magnitude more potent than BDNF' mean?

How long does it take for Dihexa to work?

Can Dihexa be taken with Semax or Selank?

Why is the 25mg capsule significantly more expensive than the 5mg?

Is there human clinical trial data for Dihexa?

Do I need a prescription for Dihexa?